Matthias Pauthner

Matthias Pauthner

Auto-generated profile, based on publicly available information

Matthias Pauthner

Department of Immunology and Microbiology, The Scripps Research Institute

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLiwei Cao
Liwei Cao
JDJolene K. Diedrich
Jolene K. Diedrich
DKDaniel W. Kulp
Daniel W. Kulp
MPMatthias Pauthner
Matthias Pauthner
LHLin He
Lin He
JPJames C. Paulson
James C. Paulson
HIV-1 envelope glycoprotein (Env) is the sole target for broadly neutralizing antibodies (bnAbs) and the focus for design of an antibody-based HIV vaccine. The Env trimer is covered by ∼90N-linked glycans, which shield the underlying protein from immune surveillance. bNAbs to HIV develop during infection, with many showing dependence on glycans for binding to Env. The ability to routinely assess the glycan type at each glycosylation site may facilitate design of improved vaccine candidates. Here we present a general mass spectrometry-based proteomics strategy that uses specific endoglycosidases to introduce mass signatures that distinguish peptide glycosites that are unoccupied or occupied by high-mannose/hybrid or complex-type glycans. The method yields >95% sequence coverage for Env, provides semi-quantitative analysis of the glycosylation status at each glycosite. We find that most glycosites in recombinant Env trimers are fully occupied by glycans, varying in the proportion of high-mannose/hybrid and complex-type glycans.

21 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDaniel W. Kulp
Daniel W. Kulp
JSJon M. Steichen
Jon M. Steichen
MPMatthias Pauthner
Matthias Pauthner
XHXiaozhen Hu
Xiaozhen Hu
TSTorben Schiffner
Torben Schiffner
WSWilliam R Schief
William R Schief
Elicitation of broadly neutralizing antibodies (bnAbs) is a primary HIV vaccine goal. Native-like trimers mimicking virion-associated spikes present nearly all bnAb epitopes and are therefore promising vaccine antigens. However, first generation native-like trimers expose epitopes for non-neutralizing antibodies (non-nAbs), which may hinder bnAb induction. We here employ computational and structure-guided design to develop improved native-like trimers that reduce exposure of non-nAb epitopes in the V3-loop and trimer base, minimize both CD4 reactivity and CD4-induced non-nAb epitope exposure, and increase thermal stability while maintaining bnAb antigenicity. In rabbit immunizations with native-like trimers of the 327c isolate, improved trimers suppress elicitation of V3-directed and tier-1 neutralizing antibodies and induce robust autologous tier-2 neutralization, unlike a first-generation trimer. The improved native-like trimers from diverse HIV isolates, and the design methods, have promise to assist in the development of a HIV vaccine.

12 September 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLiwei Cao
Liwei Cao
MPMatthias Pauthner
Matthias Pauthner
RARaiees Andrabi
Raiees Andrabi
KRKimmo Rantalainen
Kimmo Rantalainen
ZBZachary Berndsen
Zachary Berndsen
JPJames C. Paulson
James C. Paulson
As the sole target of broadly neutralizing antibodies (bnAbs) to HIV, the envelope glycoprotein (Env) trimer is the focus of vaccination strategies designed to elicit protective bnAbs in humans. Because HIV Env is densely glycosylated with 75–90 N-glycans per trimer, most bnAbs use or accommodate them in their binding epitope, making the glycosylation of recombinant Env a key aspect of HIV vaccine design. Upon analysis of three HIV strains, we here find that site-specific glycosylation of Env from infectious virus closely matches Envs from corresponding recombinant membrane-bound trimers. However, viral Envs differ significantly from recombinant soluble, cleaved (SOSIP) Env trimers, strongly impacting antigenicity. These results provide a benchmark for virus Env glycosylation needed for the design of soluble Env trimers as part of an overall HIV vaccine strategy.

27 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
Raphaëlle KlittingRaphaëlle Klitting
Raphaëlle Klitting
LKLiana E. Kafetzopoulou
Liana E. Kafetzopoulou
WTWim Thiery
Wim Thiery
GDGytis Dudas
Gytis Dudas
SGSophie Gryseels
Sophie Gryseels
SDSimon Dellicour
Simon Dellicour
Lassa fever is a severe viral hemorrhagic fever caused by a zoonotic virus that repeatedly spills over to humans from its rodent reservoirs. It is currently not known how climate and land use changes could affect the endemic area of this virus, currently limited to parts of West Africa. By exploring the environmental data associated with virus occurrence using ecological niche modelling, we show how temperature, precipitation and the presence of pastures determine ecological suitability for virus circulation. Based on projections of climate, land use, and population changes, we find that regions in Central and East Africa will likely become suitable for Lassa virus over the next decades and estimate that the total population living in ecological conditions that are suitable for Lassa virus circulation may drastically increase by 2070. By analysing geotagged viral genomes using spatially-explicit phylogeography and simulating virus dispersal, we find that in the event of Lassa virus being introduced into a new suitable region, its spread might remain spatially limited over the first decades.

10 May 2012 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
Elrike FrenzelElrike Frenzel
Elrike Frenzel
VDViktoria Doll
Viktoria Doll
MPMatthias Pauthner
Matthias Pauthner
GLGenia Lücking
Genia Lücking
SSSiegfried Scherer
Siegfried Scherer
Monika Ehling-SchulzMonika Ehling-Schulz
Monika Ehling-Schulz
Summary: Bacillus cereus causes gastrointestinal diseases and local and systemic infections elicited by the depsipeptide cereulide, enterotoxins, phospholipases, cytolysins and proteases. The PlcR‐PapR quorum sensing system activates the expression of several virulence factors, whereas the Spo0A‐AbrB regulatory circuit partially controls the plasmid‐borne cereulide synthetase (ces) operon. Here, we show that CodY, a nutrient‐responsive regulator of Gram‐positive bacteria, has a profound effect on both regulatory systems, which have been assumed to operate independently of each other. Deletion of codY resulted in downregulation of virulence genes belonging to the PlcR regulon and a concomitant upregulation of the ces genes. CodY was found to be a repressor of the ces operon, but did not interact with the promoter regions of PlcR‐dependent virulence genes in vitro, suggesting an indirect regulation of the latter. Furthermore, CodY binds to the promoter of the immune inhibitor metalloprotease InhA1, demonstrating that CodY directly links B. cereus metabolism to virulence. In vivo studies using a Galleria mellonella infection model, showed that the codY mutant was substantially attenuated, highlighting the importance of CodY as a key regulator of pathogenicity. Our results demonstrate that CodY profoundly modulates the virulence of B. cereus, possibly controlling the development of pathogenic traits in suitable host environments.

12 April 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ELEddy Kinganda - Lusamaki
Eddy Kinganda - Lusamaki
ABAllison Black
Allison Black
DMDaniel B. Mukadi
Daniel B. Mukadi
JHJames Hadfield
James Hadfield
PMPlacide Mbala-Kingebeni
Placide Mbala-Kingebeni
JTJean-Jacques Muyembe Tamfum
Jean-Jacques Muyembe Tamfum